Extracellular Volume fraction by Cardiac Computed Tomography (ECVCT): Opportunities and challenges for clinical implementation

Clicks: 3
ID: 319551
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #36 of 48 articles by views in European Heart Journal - Imaging Methods and Practice

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Cardiac computed tomography (CT)-derived extracellular volume (ECVCT) estimates myocardial interstitial expansion by quantifying the distribution of iodinated contrast within the extracellular space, providing a CT marker of focal and diffuse fibrosis as well as amyloid infiltration. In single-energy CT, ECVCT is calculated from the change in myocardial and blood-pool attenuation between non-contrast and delayed scans, adjusted for haematocrit. Spectral CT, including photon-counting CT (PCCT), can quantify ECVCT from energy-resolved data and may reduce reliance on a separate true non-contrast scan. Across several disease cohorts, ECVCT correlates well with cardiac magnetic resonance (CMR)-derived ECV and, in selected studies, with histological collagen volume fraction, supporting potential for global and regional assessment. ECVCT can add myocardial tissue characterisation to examinations already performed for coronary and structural heart disease, including opportunistic screening for concomitant transthyretin amyloidosis during transcatheter aortic valve implantation planning, risk stratification in aortic stenosis, and adjunct phenotyping after CT coronary angiography in troponin-positive acute chest pain or heart failure work-up. Furthermore, CT is more accessible, better tolerated and potentially cheaper than CMR. However, clinical adoption is potentially limited by added workflow steps due to the delayed acquisition, additional radiation exposure, and heterogeneous approaches to acquisition, reconstruction and analysis, which reduce reproducibility and complicate the definition of normalcy rates and diagnostic thresholds. Developments in PCCT, automation, and synthetic haematocrit may streamline protocols, but require further calibration and agreement-focused validation. Consensus guidance and prospective multicentre outcome studies are needed to standardise protocols, harmonise reporting, define reference ranges, and support clinically actionable thresholds.
Reference Key
openalex_W7167224423 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Rhys Gray, Elisa Rauseo, Anna Herrey, Emma Cheasty, Thomas A. Treibel, Francesca Pugliese
Journal European Heart Journal - Imaging Methods and Practice
Year 2026
DOI
10.1093/ehjimp/qyag113
URL
https://doi.org/10.1093/ehjimp/qyag113
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.